Advertisement

Nutrition and Biotechnology in Heart Disease and Cancer

  • John B. Longenecker
  • David Kritchevsky
  • Marc K. Drezner

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 369)

Table of contents

  1. Front Matter
    Pages i-x
  2. Heart Disease

    1. Gardner C. McMillan
      Pages 1-6
    2. John R. Guyton
      Pages 29-38
    3. Kenneth B. Pomerantz, Andrew C. Nicholson, David P. Hajjar
      Pages 49-64
    4. Jan L. Breslow, Marilyn Dammerman
      Pages 65-78
    5. Louis C. Smith, Randy C. Eisensmith, Savio L. C. Woo
      Pages 79-88
    6. Jason C. H. Shih, Donald W. Kelemen
      Pages 89-98
    7. Jawed Fareed, Debra Hoppensteadt, Lalitha Iyer, Michael Koza, Jeanine M. Walenga, Edward Bermes Jr.
      Pages 99-110
  3. Cancer

  4. Heart Disease and Cancer

    1. David Kritchevsky
      Pages 201-209
    2. Richard H. Adamson, Unnur P. Thorgeirsson
      Pages 211-220
  5. NIH Initiative

  6. Back Matter
    Pages 249-267

About this book

Introduction

There is a unique nutritional commonality developing in research relating to coronary heart disease and cancer. The primary aim of this conference was to provide a forum for the leading researchers, clinicians, educators and administrators in these two fields to present a program on heart disease and cancer which included a) the major historical milestones, b) the present areas of greatest interest in research and therapy, c) the latest nutritional, molecular, and biotechnological advances, and d) a perspective on the most promising areas for future research and therapy. Scientists have long contended that research marches on the feet of methodology. Thus there are numerous examples of research fields opening secondary to methodological advances. Some examples are: 1) thin layer and gas-liquid chromatography which, along with high pressure liquid chromatography have broadened the line of advances in lipid research and 2) peR and the resultant impact on molecular biological approaches to several fields of science. The organizers of this conference thought the time was propitious for bringing together knowledge on newer aspects of molecular biological research with current advances in the two major areas of degenerative disease--coronary heart disease and cancer. Our knowledge of these "killer diseases" has expanded greatly in the past few years and the advance has been catalyzed by use of an array of molecular biological techniques. Thanks to these, medical thinking in these areas is changing from considerations of treatment to strategies for prevention.

Keywords

biotechnology cancer chromatography lipide prevention research

Editors and affiliations

  • John B. Longenecker
    • 1
  • David Kritchevsky
    • 2
  • Marc K. Drezner
    • 3
  1. 1.University of North CarolinaChapel HillUSA
  2. 2.Wistar Institute of Anatomy and BiologyPhiladelphiaUSA
  3. 3.Duke University Medical CenterDurhamUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4615-1957-7
  • Copyright Information Springer-Verlag US 1995
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-5804-6
  • Online ISBN 978-1-4615-1957-7
  • Series Print ISSN 0065-2598
  • Buy this book on publisher's site
Industry Sectors
Pharma
Chemical Manufacturing
Biotechnology
Consumer Packaged Goods